Atrium is a biopharmaceutical company pioneering delivery of RNA therapeutics to the heart to transform the standard of care for people living with cardiomyopathies. Our proprietary technology leverages the targeted RNA delivery platform initially designed at Avidity, which combines the tissue selectivity of mAbs and other targeted delivery ligands with the precision of oligonucleotides. This unique combination is designed to allow selective targeting of the underlying genetic drivers of disease that were previously undruggable. Through targeted, non-viral delivery of siRNA to cardiac tissues, our approach has the potential to overcome key limitations of nonspecific viral and nanoparticle-based delivery systems, including challenges related to tissue specificity, immunogenicity, and redosing. Atrium is seeking a Postdoctoral Scientist to develop and apply in vitro cardiac assays for siRNA-based antibody–oligonucleotide conjugate (AOC) programs in rare genetic cardiomyopathies. The role will use human iPSC-derived cardiomyocytes, primary adult cardiomyocytes, and engineered cardiac tissues to assess calcium handling and contractile function. The scientist will connect these functional findings with target knockdown and downstream molecular endpoints to characterize pharmacology and support candidate selection. This is a hands-on laboratory position with ownership of a defined research project, mentorship from senior scientists, and opportunities to publish and present the work externally.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Entry Level
Education Level
Ph.D. or professional degree